GE

Nokia selected by Telehouse America to upgrade NYIIX peering exchange infrastructure in the US

Retrieved on: 
Lunedì, Giugno 3, 2024
SLA, EVPN, Interconnection, Telehouse America, Bit, IP, Computation, Cadence, Engineering, Internet, Telehouse Europe, Service, Business, Architecture, QSFP-DD, Growth, Nokia, Certification, Internet service provider

Upgrade to Telehouse’s NYIIX Peering Exchange, one of world’s largest neutral Internet Exchange Points (IXPs).

Key Points: 
  • Upgrade to Telehouse’s NYIIX Peering Exchange, one of world’s largest neutral Internet Exchange Points (IXPs).
  • Nokia to deploy IP and optical interconnection solutions allowing Telehouse to launch 10, 100 and 400 Gigabit Ethernet interconnection services.
  • – Nokia today announced that it has been selected by Telehouse America to update its NYIIX Peering Exchange production network in eight POPs located in the Northeastern United States.
  • This new project with Telehouse America and NYIIX, one of the pioneers in the US IXP market, is an excellent opportunity for Nokia.

Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retirement Income Security Act of 1974 (“ERISA”) (Brower Piven Release)

Retrieved on: 
Giovedì, Maggio 30, 2024
Armstrong World Industries, ERISA, Bristol Myers Squibb, BMY, AT&T, LMT, General Electric, AWI, Pension Benefit Guaranty Corporation, AA, Lockheed Martin

As these lawsuits allege, ERISA imposes strict fiduciary standards of conduct on employee pension plans, requiring fiduciaries to act with both prudence and loyalty and solely in the interest of employees who participate in the plan.

Key Points: 
  • As these lawsuits allege, ERISA imposes strict fiduciary standards of conduct on employee pension plans, requiring fiduciaries to act with both prudence and loyalty and solely in the interest of employees who participate in the plan.
  • The lawsuits allege that because of the transactions, plan participants and beneficiaries no longer enjoy certain benefits, including protection provided by the federally chartered Pension Benefit Guaranty Corporation.
  • According to the lawsuits, the transactions have also harmed plan participants and beneficiaries by degrading the value of their pension benefits because of Athene’s investment strategies that the lawsuits allege to be risky.
  • The lawsuits also allege that the companies profited from their decision to offload pension obligations to Athene.

GE HealthCare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida

Retrieved on: 
Giovedì, Maggio 30, 2024
Health Technology, Data Management, Other Health, Technology, Radiology, General Health, Professional Services, Biometrics, Medical Devices, Hospitals, Other Technology, Biotechnology, Software, Data Analytics, Health, Medical Supplies, Partnership, Patient, Faculty, Organization, Tampa General Hospital, Ultrasound, University, Enterprise imaging, Diagnosis, USF, University of South Florida, Research, College of Medicine, GE HealthCare, PET/CT, Teaching, Multimedia

By investing in GE HealthCare’s technologies, we’re not just focused on enhancing the patient experience, but also improving patient outcomes.

Key Points: 
  • By investing in GE HealthCare’s technologies, we’re not just focused on enhancing the patient experience, but also improving patient outcomes.
  • “Patients turn to Tampa General for world-class care, and that requires innovative technologies,” said Sherri Lewman, senior vice president, Enterprise Imaging at Tampa General Hospital.
  • In March 2023, TGH Imaging was the first in the state of Florida to install GE HealthCare’s Omni Legend digital PET/CT system .
  • “We continue to value and realize the power of our long-term partnership with Tampa General Hospital and TGH Imaging,” said Catherine Estrampes, president and CEO, U.S. and Canada at GE HealthCare.

Telix Submits NDA for New Prostate Cancer Imaging Agent

Retrieved on: 
Martedì, Maggio 28, 2024
ASX, Probability, New Drug Application, Patient, Food, Cyclotron, NDA, PSMA, Diagnosis, FDA, Nuclear pharmacy, TLX, Prostate cancer, Caregiver, Incidence, Medicine, Veteran, Physician, Kit, Food and Drug Administration, Medical imaging

The Company believes this will further expand the availability, distribution and scheduling flexibility of PSMA-PET imaging.

Key Points: 
  • The Company believes this will further expand the availability, distribution and scheduling flexibility of PSMA-PET imaging.
  • PSMA-PET imaging represents a major advancement in prostate cancer management and in the U.S. has replaced conventional imaging methods (bone scan, CT scan) as the standard of care after initial diagnosis and biochemical recurrence6.
  • Despite this major medical advancement, only a relatively small fraction of the 3.4 million men living with prostate cancer in America have undergone a PSMA-PET imaging scan7,8.
  • Mike Crosby, Founder and CEO Veterans Prostate Cancer Awareness (VPCa) stated, “Even in some of the most populous U.S. states, access to PSMA-PET imaging can be highly variable.

IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants

Retrieved on: 
Martedì, Maggio 28, 2024
Transfer, Steps, Scroll, SPC, Q&A, Google Chrome, European Medicines Agency, VET, Lead, Product lifecycle, Medical device, EMA, GVP, Canonical form, Common, NOT, Companion, PO, Chikungunya, Nature, Location, Button, Sponsor, Task force, PV, Web browser, Public, Workflow, Iris, Outcome, Purchase order, Partex Group, Prevalence, Update, Person, Medicine, Committee, Record, Approximation error, Protocol, Risk, Availability, EEA, Bulk, CVMP, Figure, Signal, PHE, Language, Zika virus, ECTD, Letter, SharePoint, Authorization, Name, Communication, Inspectorate, MIA, PRIME, MAA, Reproduction, European, Glass, Chromium, Section, Marketing, PIP, EAF, Organization, Safety, PLM, Mode, SAS, Treatment, ETF, Sunset, MAH, Standard, MSD, Directive 2001/83/EC, GMP, Public health, Self-management, Union, MSO, Report, Microsoft Excel, Browser, GCP, Civil service commission, N.B, Common Technical Document, VSI, Section 8, Qualification, Withdrawal, Date, Draft, SME, Abbreviation, Access management, Headquarters, PDF, Diagnosis, Section 4, HR, State, History, NEXT, PASS, PSMF, RPI, Save, MB, Inspection, SAP, COVID, Process, Research, Validation, VS, SAWP, Art, European Commission, Translation, Literature, PD, Public Security Section 9, Clinical trial, PRI, Brief, Submission, Annual report, ITF, KOM, Substance, Marketing authorisation, Parallel, Documentation, Contact lens, Human, CHMP, Risk management

IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants

Key Points: 

    Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retirement Income Security Act of 1974 (“ERISA”) (Brower Piven Release)

    Retrieved on: 
    Giovedì, Maggio 23, 2024
    Armstrong World Industries, ERISA, Bristol Myers Squibb, BMY, AT&T, LMT, General Electric, AWI, Pension Benefit Guaranty Corporation, AA, Lockheed Martin

    As these lawsuits allege, ERISA imposes strict fiduciary standards of conduct on employee pension plans, requiring fiduciaries to act with both prudence and loyalty and solely in the interest of employees who participate in the plan.

    Key Points: 
    • As these lawsuits allege, ERISA imposes strict fiduciary standards of conduct on employee pension plans, requiring fiduciaries to act with both prudence and loyalty and solely in the interest of employees who participate in the plan.
    • The lawsuits allege that because of the transactions, plan participants and beneficiaries no longer enjoy certain benefits, including protection provided by the federally chartered Pension Benefit Guaranty Corporation.
    • According to the lawsuits, the transactions have also harmed plan participants and beneficiaries by degrading the value of their pension benefits because of Athene’s investment strategies that the lawsuits allege to be risky.
    • The lawsuits also allege that the companies profited from their decision to offload pension obligations to Athene.

    Lantheus Announces Executive Appointments to Accelerate Innovation

    Retrieved on: 
    Mercoledì, Maggio 15, 2024
    Statistics, Neuroscience, Public key certificate, Organization, Health, Kyowa Kirin, Sorbonne University, AB, Molecular biology, University, Bristol Myers Squibb, Drug development, Merck Serono, MD, Research, CMO, LNTH, Mathematics, CSO, Drug discovery, Internal medicine, Therapy, Harvard University, Applied mathematics, Pharmacology, Pharmaceutical industry

    BEDFORD, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Jeffrey S. Humphrey, MD has been appointed Chief Medical Officer (CMO) and Jean-Claude Provost, MD has been named Chief Science Officer (CSO), effective May 28, 2024.

    Key Points: 
    • “Jeff’s clinical oncology expertise and leadership will bring immense value to Lantheus as we strengthen our position as the leading radiopharmaceutical-focused company through sustained innovation in diagnostics and therapeutics,” said Brian Markison, Chief Executive Officer, Lantheus.
    • “Jean-Claude’s deep radiopharmaceutical knowledge and experience with the Lantheus team will be invaluable in his new role as CSO, as we execute our business development strategy to enhance our pipeline and capabilities.
    • As CMO, he will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy.
    • Dr. Jean-Claude Provost, in his new CSO role, will support Lantheus’ business development activities to advance and enhance the Company’s pipeline and capabilities.

    SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

    Retrieved on: 
    Martedì, Maggio 14, 2024
    NAHB, Partnership, Tax, Patent, NEC, Investment, Calendar, Bank statement, Safety, Sale, Marketing, General Electric, Consumer Electronics Show, ANSI, AI, National Fire Protection Association, ALA, Depreciation, NFPA, National Electrical Code, International, IBS, Acceleration, Lighting

    Generated record first quarter 2024 sales of $19.0 million in revenue compared to $18.6 million for the first quarter of 2023, including sales of its advanced and smart platform plug and play products.

    Key Points: 
    • Generated record first quarter 2024 sales of $19.0 million in revenue compared to $18.6 million for the first quarter of 2023, including sales of its advanced and smart platform plug and play products.
    • SKYX’s new and existing patents enable and enhance performance of smart home and AI sensors in addition to home safety sensors.
    • The Company continues to grow its market penetration of its advanced and smart platform technologies product to both retail and commercial segments, through its e-commerce platform of over 60 websites for lighting and home décor.
    • Sales and marketing expenses amounted to $6.5 million during the first quarter of 2024, compared to $5.7 million in the first quarter of 2023.

    Genworth Financial Announces Results of Annual Meeting

    Retrieved on: 
    Giovedì, Maggio 23, 2024
    Professional Services, Insurance, Finance, Security (finance), GNW, By-law, KPMG, KPMG LLP

    Genworth Financial, Inc. (NYSE: GNW) announced the election of all nine director nominees at its 2024 annual meeting of stockholders today.

    Key Points: 
    • Genworth Financial, Inc. (NYSE: GNW) announced the election of all nine director nominees at its 2024 annual meeting of stockholders today.
    • At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation.
    • Genworth also intends to amend and restate its Bylaws to make similar conforming changes.
    • It is expected that the Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws will become effective early next month.

    GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations

    Retrieved on: 
    Mercoledì, Maggio 22, 2024
    Biotechnology, Technology, FDA, Health, Pharmaceutical, Health Technology, Medical Devices, Software, Artificial Intelligence, Surgery, Clinical Trials, Machine learning, Food, Mediastinum, Liver, CHO, Artificial intelligence, Radiation, PVA, Medical device, AI, De novo, PMA, Caption, Physicist, GE HealthCare, SNR, Food and Drug Administration

    GE HealthCare also topped the list when it was updated by the FDA in 2022 and 2023.

    Key Points: 
    • GE HealthCare also topped the list when it was updated by the FDA in 2022 and 2023.
    • “GE HealthCare is committed to pushing the boundaries of what is possible, utilizing advanced technologies like AI, to help deliver the future of healthcare.
    • GE HealthCare’s continued leadership in AI-based medical device authorizations shows our dedication to deliver ground-breaking technology that transforms healthcare and enhances patient outcomes,” said Dr. Taha Kass-Hout, Chief Science and Technology Officer at GE HealthCare.
    • Included in the list are 72 GE HealthCare 510(k) clearances or authorizations, including those from recently acquired companies, BK Medical, Caption Health and MIM Software.